Ledger.Open graph →
SEC Form D · filed May 30, 2017

Immunome Inc

Offering
$5.0M
Sold
$5.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
PHILADELPHIA, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Philip R. Wagenheim · New York, NYExec · DirectorMichael D. Rapoport · New York, NYDirectorGregory R. Harriman · Philadelphia, PADirectorMichael J. Morin · Philadelphia, PAExec · DirectorDavid D. Kutcher · Philadelphia, PAExecMichael D. Widlitz · Philadelphia, PADirectorI. W. Morris · Philadelphia, PADirectorScott D. Dessain · Philadelphia, PAExecMichael J. Glennon · Braintree, MAExec · DirectorChristopher W. Nelson · Boston, MADirectorMichael T. Levy · Louisville, KYDirectorJohn T. Taylor · Louisville, KYExec · DirectorGregory R. Harriman · Philadelphia, PADirectorMichael J. Morin · Philadelphia, PAExec · DirectorDavid D. Kutcher · Philadelphia, PAExecMichael D. Widlitz · Philadelphia, PADirectorI. W. Morris · Philadelphia, PADirectorScott D. Dessain · Philadelphia, PAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗